tiprankstipranks
Elanco provided USDA license for Canine Parvovirus Monoclonal Antibody
The Fly

Elanco provided USDA license for Canine Parvovirus Monoclonal Antibody

Elanco announced the U.S. Department of Agriculture, or USDA, has provided a conditional license for the first Canine Parvovirus Monoclonal Antibody. This is the first and only approved therapeutic solution proven to treat canine parvovirus, one of the most contagious and deadly viruses a dog can contract with a 91% mortality rate if not treated with supportive care. The treatment is the first monoclonal antibody for Elanco.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on ELAN:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles